A new embedded control and acquisition platform called CompactRIO is designed for advanced applications where small size and reliability are crucial. Powered by the company's reconfigurable I/O (RIO) ...

The LabView Control Design and Simulation Bundle extends the LabView development environment to the design, implementation, and test of real-time control systems. It includes the LabView Control ...

May 7 (Reuters) - OpenAI introduced three audio models for its developer platform on Thursday, aiming to make voice-based software agents more ‌conversational and capable of completing tasks in real ...

OpenAI said Thursday that its API will now include a number of new voice intelligence features designed to help developers create apps that can talk, transcribe, and translate conversations with users ...

OpenAI explains in more detail what’s new with the GPT-5-class GPT-Realtime-2 voice model with reasoning: GPT‑Realtime‑2 is built for live voice interactions where the model keeps the conversation ...

What’s new?: OpenAI released GPT‑Realtime‑Translate, alongside two other voice models, for real-time multilingual speech translation. Why it matters: The tool could help bridge communication gaps for ...

This page of IGN's Mass Effect wiki guide is all about the UNC: Lost Module Assignment Side-Quest, including where to find all the items and how to survive the combat encounters. This Assignment can ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Needing a new place fast, an art curator who’d been living in Utrecht decamped to the Dutch capital with about $350,000 to spend. She saw studios in three intriguing neighborhoods. By Jillian Rayfield ...

The talk/variety series “Real Time with Bill Maher,” hosted by Bill Maher, has been running for nearly two decades now, and is showing no signs of slowing down. In fact, HBO has already renewed the ...

Park is a senior health correspondent at TIME. She covers the COVID-19 pandemic, new drug developments in cancer and Alzheimer’s disease, mental health, HIV, CRISPR, and advances in gene therapy, ...